Loading ...Why BWXT jumped nearly 19% today (August 5, 2025)
Major earnings beat and raised guidance
-
BWX Technologies reported stellar Q2 2025 results: adjusted EPS of $1.02/share, a 29% beat over the $0.79 consensus, and revenue of $764M, about 12% higher than a year ago and well above expectations BWX Technologies Investor Relations+15TradingView+15Investing.com+15.
-
Management upped its full-year guidance: adjusted EPS now expected to be $3.65–$3.75 (previously $3.40–$3.55), revenue guidance raised to ~$3.1 B, and free cash flow guidance increased to $275–$285 M Investors.com+1.
Record backlog & contract wins
-
The company announced a record backlog of ~$6 B, driven by robust bookings across government and commercial segments Simply Wall St+1.
-
It also secured sizeable $2.6 B in new U.S. Naval contracts, including for Virginia- and Columbia-class subs and related reactor components Investing.com.
Sector tailwinds & strategic policy momentum
-
Investor enthusiasm in nuclear is rising. Analysts highlight BWXT’s radiopharma business—particularly isotope production—as a strong near-term growth driver in a market projected to reach $30 B by 2030 MarketWatch+13Investors.com+13StockAnalysis+13.
-
In addition, the Trump administration’s plans to fast-track a 100 kW nuclear reactor for the moon by 2030, along with regulatory reforms, have boosted sentiment across the sector Investors.com.
Market volume & technical signals
-
Today’s volume surged to roughly $245M in trading volume, signaling strong investor interest Quiver Quantitative+1.
-
Technical indicators also turned bullish, with a sustained price rally and expanding volume, flagging a compelling near‑term technical setup StockInvestQuiver Quantitative.
🧭 Summary at a glance
| Catalyst | Description |
|---|---|
| Earnings surprise | EPS and revenue well above estimates |
| Upgraded guidance | Higher projections for full-year earnings, cash flow |
| Strength in backlog | Record $6B backlog and major naval contracts |
| Sector momentum | Rising radiopharma demand and supportive nuclear policy |
| Technical validation | High trading volumes and positive chart signals |